Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-broMo-4-ethyoxylbenzonitrile is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

136366-42-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 136366-42-2 Structure
  • Basic information

    1. Product Name: 3-broMo-4-ethyoxylbenzonitrile
    2. Synonyms: 3-broMo-4-ethyoxylbenzonitrile;3-broMo-4-ethoxybenzonitrile
    3. CAS NO:136366-42-2
    4. Molecular Formula: C9H8BrNO
    5. Molecular Weight: 226.06992
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 136366-42-2.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 3-broMo-4-ethyoxylbenzonitrile(CAS DataBase Reference)
    10. NIST Chemistry Reference: 3-broMo-4-ethyoxylbenzonitrile(136366-42-2)
    11. EPA Substance Registry System: 3-broMo-4-ethyoxylbenzonitrile(136366-42-2)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 136366-42-2(Hazardous Substances Data)

136366-42-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 136366-42-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,6,3,6 and 6 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 136366-42:
(8*1)+(7*3)+(6*6)+(5*3)+(4*6)+(3*6)+(2*4)+(1*2)=132
132 % 10 = 2
So 136366-42-2 is a valid CAS Registry Number.

136366-42-2Downstream Products

136366-42-2Relevant articles and documents

COMPOUNDS AND USES THEREOF

-

Page/Page column 202; 203, (2018/05/17)

The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

2 - (3-cyano-4-alkoxy) phenyl-4-substituted thiazole-5- formic acid class compound, composition and its preparation and use

-

Paragraph 0104; 0107; 0108, (2016/10/07)

The invention relates to a 2-(3-cyano-4-alkoxy) phenyl-4-substituted thiazole-5-formic acid compound which has xanthine oxidase inhibitory activity and is shown in a general formula I, a composition and preparation methods thereof. The invention also relates to applications of the compound and the composition thereof to preparation of medicaments for treating and/or preventing hyperuricemia and gout diseases. In the formula I, R2 is substituted or unsubstituted phenyl or a substituted or unsubstituted heteroaromatic radical, R1 is a substitutive aliphatic group of a straight chain or a branched chain, substituted or unsubstituted alicyclic hydrocarbonyl or substituted or unsubstituted aryl alkyl and A is an oxygen atom, a sulfur atom or a nitrogen atom.

Ruthenium-catalyzed intramolecular selective halogenation of O-methylbenzohydroximoyl halides: A new route to halogenated aromatic nitriles

Chinnagolla, Ravi Kiran,Pimparkar, Sandeep,Jeganmohan, Masilamani

supporting information, p. 3146 - 3148 (2013/06/04)

The intramolecular halogenation of O-methylbenzohydroximoyl halides in the presence of a Ru catalyst and the ligand diphenylacetylene afforded halo substituted aromatic nitriles in a highly regioselective manner. Further, substituted nitriles were converted into substituted tetrazole derivatives in the presence of NaN3 and I2.

NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS

-

Page/Page column 50, (2008/12/07)

The present application relates to thiazolylidene containing compounds of formula (I) wherein R1, R2, R3, R4, L2 and A are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

PYRROLE AND PYRAZOLE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS

-

Page/Page column 69, (2008/06/13)

The present invention relates to pyrrole and pyrazole compounds of formula (I) and their pharmaceutically acceptable salts, and further relates to their use in treating schizophrenia, cognitive deficits associated with schizophrenia, Alzheimer's disease, dementia of the Alzheimer's type, mild cognitive impairment, or depression. The compounds act as potentiators on glutamate receptors, in particular AMPA and the GluR family.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 136366-42-2